Opexa Therapeutics Inc (NASDAQ: OPXA)
Yesterday, OPXA had an amazing day in the market. Leading up to a presentation from the company’s CEO, investor excitement drove the stock up. During and after the presentation, we saw more upward momentum. However, the story seems to be a bit different today. Today, Opexa is having a tough day in the market. So below, we’ll talk about what we saw from the presentation, what we’re seeing in the market today, and what we can expect to see from the stock moving forward. So, let’s get right to it.
Opexa Therapeutics’ Presentation Was A Hit!
Yesterday, OPXA President and CEO, Neil K. Warma gave a presentation at the 2015 Microcap Conference. Yesterday, I wrote a post that went into a bit of detail about the presentation and what we saw, to read it click here! Nonetheless, there were four main points that seemed to show all positive news for the company. First off, financial data looked great. As a clinical stage biopharmaceutical company with no debt, OPXA has some bragging rights!
In the presentation, we also learned about OPX 212, the company’s newest candidate; and about the progress of Tcelna, the company’s flagship candidate. All in all, data surrounding them both was great. Tcelna is fast tracking to FDA approval and OPX 212 looks promising as a treatment for an ailment with no approved treatments.
Finally, Warma talked about the technology the company has developed that will allow them to customize treatments on a patient by patient basis; leading to higher efficiency treatments. All in all, the presentation was great and investors got excited.
OPXA Declined Today
Unfortunately, it seems as though the tides have changed. After a great climb yesterday, OPXA closed in the red today; losing 3.44%. However, I have to say that I’m not too concerned about the declines. As a matter of fact, I’m not concerned at all. When I see things like this, I see natural market movement. The bottom line is that price movement in the market is a series of overreactions; each pushing the stock value higher or lower than it should be. Essentially, an overreaction brought the price up too high yesterday, and we’re seeing a correction today. However, these pull backs are a great opportunity to get in on the gains at a low price!
What We Can Expect To See Moving Forward
All in all, I’ve got an incredibly bullish outlook when it comes to OPXA. I think that the presentation yesterday was a big step. Through the presentation, the company has shown that not only are they working on expanding their pipeline, their flagship candidate is growing more and more promising. As I said yesterday, I’m also impressed by the talents of the management team, scientists and doctors that all take part in the growth at OPXA. With that said, we may see short term declines on the way to the top, but in my opinion, the stock will continue to grow.
What Do You Think?
Where do you think OPXA is headed and why? Let us know in the comments below!
